India Cellular Immunotherapy Market (2025-2031) | Analysis, Outlook, Trends, Share, Companies, Growth, Industry, Size & Revenue, Value, Forecast, Competitive Landscape, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Cellular Immunotherapy Market Revenues & Volume, 2021 & 2031F

3.3 India Cellular Immunotherapy Market - Industry Life Cycle

3.4 India Cellular Immunotherapy Market - Porter's Five Forces

3.5 India Cellular Immunotherapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 India Cellular Immunotherapy Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 India Cellular Immunotherapy Market Revenues & Volume Share, By End Use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing investments in healthcare infrastructure and research and development

4.2.3 Rising awareness about the benefits of cellular immunotherapy

4.3 Market Restraints

4.3.1 High cost associated with cellular immunotherapy treatments

4.3.2 Lack of skilled healthcare professionals specialized in cellular immunotherapy

4.3.3 Stringent regulations and lengthy approval processes for cellular immunotherapy products

6.1 India Cellular Immunotherapy Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 India Cellular Immunotherapy Market Revenues & Volume, By Therapy Type, 2021- 2031F

6.1.3 India Cellular Immunotherapy Market Revenues & Volume, By CAR T Cell Therapy, 2021- 2031F

6.1.4 India Cellular Immunotherapy Market Revenues & Volume, By Dendritic Cell Therapy, 2021- 2031F

6.1.5 India Cellular Immunotherapy Market Revenues & Volume, By NK Cell Therapy, 2021- 2031F

6.1.6 India Cellular Immunotherapy Market Revenues & Volume, By TIL Therapy, 2021- 2031F

6.1.7 India Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Cellular Immunotherapy Market, By Indication

6.2.1 Overview and Analysis

6.2.2 India Cellular Immunotherapy Market Revenues & Volume, By B-cell Malignancies, 2021- 2031F

6.2.3 India Cellular Immunotherapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.4 India Cellular Immunotherapy Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.5 India Cellular Immunotherapy Market Revenues & Volume, By Renal Cell Carcinoma, 2021- 2031F

6.2.6 India Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F

6.3 India Cellular Immunotherapy Market, By End Use

6.3.1 Overview and Analysis

6.3.2 India Cellular Immunotherapy Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 India Cellular Immunotherapy Market Revenues & Volume, By Cancer Institutes, 2021- 2031F

6.3.4 India Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Cellular Immunotherapy Market Export to Major Countries

7.2 India Cellular Immunotherapy Market Imports from Major Countries

8.1 Number of clinical trials for cellular immunotherapy in India

8.2 Adoption rate of cellular immunotherapy treatments in different regions of India

8.3 Number of partnerships and collaborations between research institutions and pharmaceutical companies in the field of cellular immunotherapy

9.1 India Cellular Immunotherapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 India Cellular Immunotherapy Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 India Cellular Immunotherapy Market Opportunity Assessment, By End Use, 2021 & 2031F

10.1 India Cellular Immunotherapy Market Revenue Share, By Companies, 2024

10.2 India Cellular Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters